Search in:

European Clinical Respiratory Journal Volume 7, 2020 - Issue 1

Submit an article Journal homepage

Open access

2,597

Views

CrossRef citations to date

Altmetric

Research Article

Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis

Mariann I. Lasseniusa Medaffcon Oy, Espoo, FinlandView further author information

Iiro Toppilaa Medaffcon Oy, Espoo, FinlandView further author information

Nora Pöntynenb Boehringer Ingelheim KY, Helsinki, FinlandView further author information

Laura Kasslinb Boehringer Ingelheim KY, Helsinki, FinlandView further author information

Jaana Kaunistoc Department of Pulmonary Diseases, Turku University Hospital and University of Turku, Turku, FinlandView further author information

Maritta Kilpeläinenc Department of Pulmonary Diseases, Turku University Hospital and University of Turku, Turku, FinlandView further author information

Tarja Laitinend Hospital administration, Tampere University Hospital, Tampere, FinlandCorrespondence[email protected]
View further author information

show all

Article: 1702618 | Received 03 Jun 2019, Accepted 28 Nov 2019, Published online: 17 Dec 2019

Cite this article
https://doi.org/10.1080/20018525.2019.1702618
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (10)

Maria Jesus Rodríguez-Nieto, Esteban Cano-Jiménez, Ana D. Romero Ortiz, Ana Villar, Marta Morros, Alba Ramon & Silvia Armengol. (2023) Economic Burden of Idiopathic Pulmonary Fibrosis in Spain: A Prospective Real-World Data Study (OASIS Study). PharmacoEconomics 41:8, pages 999-1010.
Crossref

Sara Tomassetti, Claudia Ravaglia, Sara Piciucchi, Jay Ryu, Athol Wells, Luca Donati, Alessandra Dubini, Catherine Klersy, Valentina Luzzi, Leonardo Gori, Elisabetta Rosi, Federico Lavorini & Venerino Poletti. (2023) Historical eye on IPF: a cohort study redefining the mortality scenario. Frontiers in Medicine 10.
Crossref

Maritta Kilpeläinen, Tuuli Hirvonen, Katariina Perkonoja & Samuli Hirsjärvi. (2023) Clinical Characteristics and Disease Course of Fibrosing Interstitial Lung Disease Patients in a Real-World Setting. Medicina 59:2, pages 281.
Crossref

Michael Kreuter, Francesco Del Galdo, Corinna Miede, Dinesh Khanna, Wim A. Wuyts, Laura K. Hummers, Margarida Alves, Nils Schoof, Christian Stock & Yannick Allanore. (2022) Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis. Arthritis Research & Therapy 24:1.
Crossref

Wim A. Wuyts, Caroline Dahlqvist, Hans Slabbynck, Marc Schlesser, Natacha Gusbin, Christophe Compere, Sofie Maddens, Shemra Rizzo, Klaus-Uwe Kirchgaessler, Karen Bartley & Benjamin Bondue. (2022) Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry. Pulmonary Therapy 8:2, pages 181-194.
Crossref

Siavash Bolourani, Ezgi Sari, Max Brenner & Ping Wang. (2022) The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice. PLOS ONE 17:4, pages e0266163.
Crossref

Anju Yadav, Rahul Saxena, Aayush Kumar, Tarandeep Singh Walia, Atef Zaguia & S. M. Mostafa Kamal. (2022) FVC-NET: An Automated Diagnosis of Pulmonary Fibrosis Progression Prediction Using Honeycombing and Deep Learning. Computational Intelligence and Neuroscience 2022, pages 1-12.
Crossref

Qiang Zheng, Ingrid A. Cox, Julie A. Campbell, Qing Xia, Petr Otahal, Barbara de Graaff, Tamera J. Corte, Alan K.Y. Teoh, E. Haydn Walters & Andrew J. Palmer. (2022) Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. ERJ Open Research 8:1, pages 00591-2021.
Crossref

Nancy G. Casanova, Tong Zhou, Manuel L. Gonzalez-Garay, Yves A. Lussier, Nadera Sweiss, Shwu-Fan Ma, Imre Noth, Kenneth S. Knox & Joe G.N. Garcia. (2021) MicroRNA and protein-coding gene expression analysis in idiopathic pulmonary fibrosis yields novel biomarker signatures associated to survival. Translational Research 228, pages 1-12.
Crossref

Simon Cruwys, Peter Hein, Bob Humphries & Darcey Black. (2020) Drug discovery and development in idiopathic pulmonary fibrosis: challenges and opportunities. Drug Discovery Today 25:12, pages 2277-2283.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis

Articles from other publishers (10)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Forced Vital Capacity (FVC) decline, mortality and healthcare resource utilization in idiopathic pulmonary fibrosis

Citations (10)

Articles from other publishers (10)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date